Abstract P6-15-03: Phase Ib Trial of the Gamma Secretase Inhibitor (GSI), MK-0752 Followed by Docetaxel in Locally Advanced or Metastatic Breast Cancer
2010 · Cancer Research · 3 citations
https://doi.org/10.1158/0008-5472.sabcs10-p6-15-03
R
R.M. Layman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
18
Papers
28
Citations
3
h-index
0
i10-index
R.M. Layman is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Advanced Breast Cancer Therapies & HER2/EGFR in Cancer Research & Breast Cancer Treatment Studies. The author has an h-index of 3, co-authored 16 publications.
Papers by this author
works202P Early brain relapse in stage III inflammatory breast cancer occurs independent of molecular subtype
2025 · ESMO Open · 0 citations
https://doi.org/10.1016/j.esmoop.2025.104756
Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer
2026 · ESMO Open · 0 citations
https://doi.org/10.1016/j.esmoop.2025.106050
Abstract PS2-10-30: Tumor-associated macrophage (TAMs) and cancer-associated fibroblasts (CAFs) profiles in invasive lobular carcinoma (ILC) vs no special type (NST)
2026 · Clinical Cancer Research · 0 citations
https://doi.org/10.1158/1557-3265.sabcs25-ps2-10-30
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat